GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

THC Farmaceuticals CBDG · USD

Industrials · US listing · 🇺🇸 United States

Compare

0.01

-49.15%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2014FY2025

Net income

−$10,395

FY2014FY2025

Free cash flow

—

FY2014FY2025

Shareholders' equity

$3.2m

FY2014FY2025

Income statement

Fiscal years

FY2025FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2014
Revenue——$10,000$2,234$7,575$10,193$12,208$12,949$17,073$19
Operating income−$20,791−$29,952−$8,491−$17,810−$32,700−$158,090−$15,240−$7,300−$136,120−$24
Net income−$10,395−$14,976$426,905−$8,420−$60,445−$498,566−$15,245−$7,300−$136,117−$31
Diluted earnings per share-0.00-0.000.02-0.00-0.00-0.03-0.00-0.00-0.01-0.00

Balance sheet

At each fiscal year end

FY2025FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2014
Total assets$2.7m$2.7m$2.8m$2.8m$2.3m$2.5m$2.8m$1.8m$1.8m$48
Cash and short-term investments—$1,714$1,714$18,839$2,588$2,550$31,714$1,714$1,714$1
Total liabilities$141,518$142,095$142,095$587,662$551,398$1.1m$958,964$959,672$952,977$96
Debt$115,269$141,518$141,518$372,661$342,724$916,724$916,724$915,080$908,080$78
Shareholders' equity$3.2m$3.2m$3.2m$2.8m$2.3m$2.0m$1.8m$792,473$799,773−$48
Shares outstanding18m18m18m17m18m17m18m18m18m12m

Cash flow

Fiscal years

FY2025FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2014
Cash from operations—$635,537$317,885−$11,761−$2,206−$134,237−$9,150−$7,000−$169,787−$19
Capital spending—−$3−$5−$1——————
Free cash flow—$635,534$317,880−$11,762−$2,206−$134,237−$9,150−$7,000−$169,787−$19

Latest quarters

By quarter end

Jun 2022Mar 2022Dec 2021Sept 2020Dec 2019Jun 2019Mar 2019Dec 2018
Revenue——$10,000$7,600$5,027$7,976$3,742$3,500
Operating income−$6,320−$11,280−$1,690−$32,700−$9,680−$49,050−$41,770−$30,500
Net income−$3,163−$5,637−$844−$60,500$57,774−$443,936−$20,928−$15,300
Diluted earnings per share-0.00-0.00-0.00-0.000.00-0.03-0.00-0.00
Total assets$2.8m$2.8m$2.8m$2.3m$1.7m$2.5m$3.4m$2.8m
Cash and short-term investments$6,869$10,145$11,458$2,600$3,363$2,034$9,321$42,500
Debt$386,297$382,779$342,030$458,000$341,724$916,724$916,724$965,700
Shareholders' equity$2.8m$2.8m$2.8m$2.3m$1.7m$2.0m$2.4m$1.8m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income5.3%-33.4%100.7%
Net income7.3%-53.9%83.6%

Valuation history

At each fiscal year end

FY2025
Price to earnings-0.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return41790671%307003%10%160630%5521%5417%-55%540%407970%-8%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.